The absence of CHOP reduced ER stress and disrupted the pathological processes associated with mutant COMP, providing a potential mechanism for these therapeutic effects, consistent with other studies showing decreased osteoarthritis damage in mice lacking CHOP [39,40,41,42]. This evidence concerns the gene DDIT3 and osteoarthritis.